Juliana K. Ilmain

Juliana K. Ilmain

Auto-generated profile, based on publicly available information

Juliana K. Ilmain

Department of Microbiology, New York University Grossman School of Medicine, New York, New York, 10016, USA

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2021 in eLife
Verified
Journal Article
Open access
ZDZharko Daniloski
Zharko Daniloski
TJTristan X Jordan
Tristan X Jordan
JIJuliana K Ilmain
Juliana K Ilmain
XGXinyi Guo
Xinyi Guo
GBGira Bhabha
Gira Bhabha
NSNeville E Sanjana
Neville E Sanjana
A novel variant of the SARS-CoV-2 virus carrying a point mutation in the Spike protein (D614G) has recently emerged and rapidly surpassed others in prevalence. This mutation is in linkage disequilibrium with an ORF1b protein variant (P314L), making it difficult to discern the functional significance of the Spike D614G mutation from population genetics alone. Here, we perform site-directed mutagenesis on wild-type human-codon-optimized Spike to introduce the D614G variant. Using multiple human cell lines, including human lung epithelial cells, we found that the lentiviral particles pseudotyped with Spike D614G are more effective at transducing cells than ones pseudotyped with wild-type Spike. The increased transduction with Spike D614G ranged from 1.3- to 2.4-fold in Caco-2 and Calu-3 cells expressing endogenous ACE2 and from 1.5- to 7.7-fold in A549ACE2 and Huh7.5ACE2 overexpressing ACE2. Furthermore, trans-complementation of SARS-CoV-2 virus with Spike D614G showed an increased infectivity in human cells. Although there is minimal difference in ACE2 receptor binding between the D614 and G614 Spike variants, the G614 variant is more resistant to proteolytic cleavage, suggesting a possible mechanism for the increased transduction.

20 January 2023 in Cell Host & Microbe
Verified
Journal Article
Open access
SDSophie Dyzenhaus
Sophie Dyzenhaus
MSMitchell J. Sullivan
Mitchell J. Sullivan
BABremy Alburquerque
Bremy Alburquerque
DBDaiane Boff
Daiane Boff
AGAdriana van de Guchte
Adriana van de Guchte
VTVictor Torres
Victor Torres
The epidemic community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) USA300 lineage has recently become a leading cause of hospital-associated bloodstream infections (BSIs). Here, we leveraged this recent introduction into hospitals and the limited genetic variation across USA300 isolates to identify mutations that contribute to its success in a new environment. We found that USA300 BSI isolates exhibit altered virulence regulation. Using comparative genomics to delineate the genes involved in this phenotype, we discovered repeated and independent mutations in the transcriptional regulator sarZ. Mutations in sarZ resulted in increased virulence of USA300 BSI isolates in a murine model of BSI. The sarZ mutations derepressed the expression and production of the surface protein ClfB, which was critical for the pathogenesis of USA300 BSI isolates. Altogether, these findings highlight ongoing evolution of a major MRSA lineage and suggest USA300 strains can optimize their fitness through altered regulation of virulence.

19 April 2021 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
SPSofya S. Perelman
Sofya S. Perelman
DJDavid B. A. James
David B. A. James
KBKristina M. Boguslawski
Kristina M. Boguslawski
CNChase W. Nelson
Chase W. Nelson
JIJuliana K. Ilmain
Juliana K. Ilmain
VTVictor Torres
Victor Torres

7 August 2018 in Oecologia
Verified
Journal Article
Closed access
PDF file
CSCatherine Searle
Catherine Searle
BHBaylie R. Hochstedler
Baylie R. Hochstedler
AMAbigail M. Merrick
Abigail M. Merrick
JIJuliana K. Ilmain
Juliana K. Ilmain
MWMaggie A. Wigren
Maggie A. Wigren

12 August 2025 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JSJulia Sproch
Julia Sproch
RPRachel Prescott
Rachel Prescott
HKHee Jin Kim
Hee Jin Kim
CCChrispin Chaguza
Chrispin Chaguza
SGSandra Gonzalez
Sandra Gonzalez
VTVictor Torres
Victor Torres
Staphylococcus aureus is a global health concern, resulting in significant disease burden in both hospital and community settings. To establish infection, the bacteria must contend with a multitude of host defense mechanisms, including "nutritional immunity", in which nutrients are sequestered away from invading pathogens. Importantly, S. aureus requires iron for growth during infection, which it acquires through the lysis of erythrocytes (hemolysis). HlgAB, a secreted bi-component pore forming toxin, contributes to the ability of S. aureus to lyse erythrocytes to release heme iron. HlgAB consists of two subunits, the S-subunit HlgA and the F-subunit HlgB. Prior work has shown that the hemolytic activity of HlgAB is dependent on the binding of HlgA to the host receptor Duffy Antigen Receptor for Chemokines (DARC). Here we show that HlgB binds the surface of erythrocytes independently of DARC or HlgA. Our comparative genomic analysis reveals high conservation of hlgA and hlgB genes across S. aureus lineages. By performing structure-function studies, we identified a series of loops within the rim domain of HlgB that are required for the binding of HlgB to erythrocytes and erythrocyte lysis by HlgAB. The importance of HlgB-mediated host targeting was validated in a tissue culture model of S. aureus-mediated lysis of primary human erythrocytes, in an in vivo murine model of intoxication, and during in vivo systemic infection. Altogether, these findings expand our mechanistic insights into how S. aureus overcomes nutritional immunity, and the role of HlgB in S. aureus pathophysiology.

4 October 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
JIJuliana K. Ilmain
Juliana K. Ilmain
SPSofya S. Perelman
Sofya S. Perelman
MPMaria C. Panepinto
Maria C. Panepinto
IIIrnov Irnov
Irnov Irnov
NCNicolas Coudray
Nicolas Coudray
VTVictor Torres
Victor Torres
Staphylococcus aureus (S. aureus) is a serious global pathogen that causes a diverse range of invasive diseases. S. aureus utilizes a family of pore-forming toxins, known as bi-component leukocidins, to evade the host immune response and promote infection. Among these is LukAB (leukocidin A/leukocidin B), a toxin that assembles into an octameric β-barrel pore in the target cell membrane, resulting in host cell death. The established cellular receptor for LukAB is CD11b of the Mac-1 complex. Here, we show that hydrogen voltage-gated channel 1 is also required for the cytotoxicity of all major LukAB variants. We demonstrate that while each receptor is sufficient to recruit LukAB to the plasma membrane, both receptors are required for maximal lytic activity. Why LukAB requires two receptors, and how each of these receptors contributes to pore-formation remains unknown. To begin to resolve this, we performed an alanine scanning mutagenesis screen to identify mutations that allow LukAB to maintain cytotoxicity without CD11b. We discovered 30 mutations primarily localized in the stem domains of LukA and LukB that enable LukAB to exhibit full cytotoxicity in the absence of CD11b. Using crosslinking, electron microscopy, and hydroxyl radical protein footprinting, we show these mutations increase the solvent accessibility of the stem domain, priming LukAB for oligomerization. Together, our data support a model in which CD11b binding unlatches the membrane penetrating stem domains of LukAB, and this change in flexibility promotes toxin oligomerization.